Aldehyde metabolism in the cardiovascular system

Molecular BioSystems

Volumn 3, Issue 2, 2007, Pages 136-150

  Conklin, Daniel ^a,b   Prough, Russell ^b   Bhatanagar, Aruni ^a,b  

^a Institute of Molecular Cardiology   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALCOHOL DEHYDROGENASE; ALDEHYDE; ALDEHYDE DEHYDROGENASE; CARBONYL REDUCTASE (NADPH); CYTOCHROME P450; GLUTATHIONE TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL; BIOLOGICAL MODEL; CARDIOVASCULAR SYSTEM; ENZYMOLOGY; HUMAN; LIPID PEROXIDATION; METABOLISM; PHYSIOLOGY; REVIEW;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALCOHOL OXIDOREDUCTASES; ALDEHYDE DEHYDROGENASE; ALDEHYDES; ANIMALS; CARDIOVASCULAR SYSTEM; CYTOCHROME P-450 ENZYME SYSTEM; GLUTATHIONE TRANSFERASE; HUMANS; LIPID PEROXIDATION; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL;

EID: 33846471592     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/b612702a     Document Type: Review

References (190)

1. R. O. Beauchamp, Jr. D. A. Andjelkovich A. D. Kligerman K. T. Morgan H. D. Heck A critical review of the literature on acrolein toxicity Crit. Rev. Toxicol. 1985 14 309 380
2. P. J. O'Brien A. G. Siraki N. Shangari Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health Crit. Rev. Tox. 2005 35 609 662
3. A. Bhatnagar Cardiovascular pathophysiology of environmental pollutants Am. J. Physiol Heart Circ. Physiol. 2004 286 H479 H485
4. V. J. Feron J. P. Groten P. J. van Bladeren Exposure of humans to complex chemical mixtures: hazard identification and risk assessment Arch. Toxicol. Suppl 1998 20 363 373
5. K. V. Ramana A. Bhatnagar S. Srivastava U. C. Yadav S. Awasthi Y. C. Awasthi S. K. Srivastava Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth J. Biol. Chem. 2006 281 17652 17660
6. S. P. Wolff Z. Y. Jiang J. V. Hunt Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biol. Med. 1991 10 339 52
7. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 2001 414 813 20
8. J. L. Evans I. D. Goldfine B. A. Maddux G. M. Grodsky Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. [Review] [416 refs] Endocrine Rev. 2002 23 5 599 622
9. J. L. Wautier A. M. Schmidt Protein glycation: a firm link to endothelial cell dysfunction. Circ. Res. 2004 95 3 233 8
10. M. A. Smith P. L. Richey S. Taneda R. K. Kutty L. M. Sayre V. M. Monnier G. Perry Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1994 738 447 54
11. H. Choei N. Sasaki M. Takeuchi T. Yoshida W. Ukai S. Yamagishi S. Kikuchi T. Saito Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease Acta Neuropathol. 2004 108 189 193
12. D. Aronson Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 2003 21 3 12
13. H. Kato N. van Chuyen T. Shinoda F. Sekiya F. Hayase Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats Biochim. Biophys. Acta 1990 1035 71 6
14. D. V. Zyzak J. M. Richardson S. R. Thorpe J. W. Baynes Formation of reactive intermediates from Amadori compounds under physiological conditions Arch. Biochem. Biophys. 1995 316 547 54
15. B. S. Szwergold F. Kappler T. R. Brown Identification of fructose 3-phosphate in the lens of diabetic rats Science 1990 247 451 4
16. D. G. Dyer J. A. Blackledge S. R. Thorpe J. W. Baynes Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo J. Biol. Chem. 1991 266 11654 60
17. F. Hayase R. H. Nagaraj S. Miyata F. G. Njoroge V. M. Monnier Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo J. Biol. Chem. 1989 264 3758 64
18. S. F. Yan R. Ramasamy Y. Naka A. M. Schmidt Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond Circ. Res. 2003 93 1159 69
19. T. Niwa T. Miyazaki T. Katsuzaki N. Tatemichi Y. Takei Serum levels of 3-deoxyglucosone and tissue contents of advanced glycation end products are increased in streptozotocin-induced diabetic rats with nephropathy Nephron 1996 73 580 5
20. H. Yamada S. Miyata N. Igaki H. Yatabe Y. Miyauchi T. Ohara M. Sakai H. Shoda M. Oimomi M. Kasuga Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction J. Biol. Chem. 1994 269 20275 80
21. T. Niwa N. Takeda H. Yoshizumi A. Tatematsu M. Ohara S. Tomiyama K. Niimura Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum Biochem. Biophys. Res. Commun. 1996 837 843
22. J. L. Wautier A. M. Schmidt Protein glycation: a firm link to endothelial cell dysfunction Circ. Res. 2004 95 233 8
23. S. F. Yan R. Ramasamy Y. Naka A. M. Schmidt Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ. Res. 2003 93 1159 69
24. J. P. Richard Kinetic parameters for the elimination reaction catalyzed by triosephosphate isomerase and an estimation of the reaction's physiological significance Biochemistry 1991 30 4581 4585
25. V. Riddle F. W. Lorenz Nonenzymic, polyvalent anion-catalyzed formation of methylglyoxal as an explanation of its presence in physiological systems J. Biol. Chem. 1968 243 2718 2724
26. J. P. Richard Kinetic parameters for the elimination reaction catalyzed by triosephosphate isomerase and an estimation of the reaction's physiological significance Biochemistry 1991 30 4581 4585
27. G. A. Lyles J. Chalmers The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery Biochem. Pharmacol. 1992 43 1409 1414
28. T. Tressel R. Thompson L. R. Zieske M. I. Menendez L. Davis Interaction between l-threonine dehydrogenase and aminoacetone synthetase and mechanism of aminoacetone production J. Biol. Chem. 1986 261 16428 16437
29. Y. A. Aleksandrovskii Antithrombin III, C1 inhibitor, methylglyoxal, and polymorphonuclear leukocytes in the development of vascular complications in diabetes mellitus Thromb. Res. 1992 67 179 189
30. J. E. Harrison F. A. Saeed Radical acetoacetate oxidation by myeloperoxidase, lactoperoxidase, prostaglandin synthetase, and prostacyclin synthetase: implications for atherosclerosis Biochem. Med. 1983 29 149 163
31. S. A. Phillips D. Mirrlees P. J. Thornalley Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil Biochem. Pharmacol. 1993 46 805 811
32. A. C. McLellan P. J. Thornalley J. Benn P. H. Sonksen Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications Clin. Sci. (London) 1994 87 21 29
33. T. Oya N. Hattori Y. Mizuno S. Miyata S. Maeda T. Osawa K. Uchida Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts J. Biol. Chem. 1999 274 18492 18502
34. E. W. Randell S. Vasdev V. Gill Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography J. Pharmacol. Toxicol. Methods 2005 51 153 7
35. A. A. Akhand K. Hossain H. Mitsui M. Kato T. Miyata R. Inagi J. Du K. Takeda Y. Kawamoto H. Suzuki K. Kurokawa I. Nakashima Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells Free Radical Biol. Med. 2001 31 20 30
36. T. Chang R. Wang L. Wu Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells Free Radical Biol. Med. 2005 38 286 93
37. L. Wu The pro-oxidant role of methylglyoxal in mesenteric artery smooth muscle cells Can. J. Physiol. Pharmacol. 2005 83 63 8
38. X. Fan R. Subramaniam M. F. Weiss V. M. Monnier Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation Arch. Biochem. Biophys. 2003 409 274 86
39. M. L. Fa C. G. Schalkwijk M. Engelse V. W. van Hinsbergh Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs Thromb. Haemostasis 2006 95 320 8
40. K. Nakajou S. Horiuchi M. Sakai K. Hirata M. Tanaka M. Takeya T. Kai M. Otagiri CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells J. Biochem. 2005 137 607 16
41. R. Nagai K. Matsumoto X. Ling H. Suzuki T. Araki S. Horiuchi Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor Diabetes 2000 49 1714 23
42. B. E. Brown R. T. Dean M. J. Davies Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells Diabetologia 2005 48 361 9
43. M. Passarelli C. Tang T. O. McDonald K. D. O'Brien R. G. Gerrity J. W. Heinecke J. F. Oram Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells Diabetes 2005 54 2198 205
44. A. Benedetti M. Comporti H. Esterbauer Identification of 4-Hydroxynoneal As A Cyto-Toxic Product Originating from the Peroxidation of Liver Microsomal Lipids Biochim. Biophys. Acta 1980 62 281 296
45. H. Esterbauer R. J. Schaur H. Zollner Chemistry and Biochemistry of 4-Hydroxynonenal, Malonaldehyde and Related Aldehydes Free Radical Biol. Med. 1991 11 81 128
46. A. Benedetti M. Comporti R. Fulceri H. Esterbauer Cyto-Toxic Aldehydes Originating from the Peroxidation of Liver Microsomal Lipids - Identification of 4,5-Dihydroxydecenal Biochim. Biophys. Acta 1984 792 172 181
47. 3-Poisoned Rats Biochim. Biophys. Acta 1982 712 628 638
48. A. J. Lusis Atherosclerosis Nature 2000 407 233 241
49. A. Yoritaka N. Hattori K. Uchida M. Tanaka E. R. Stadtman Y. Mizuno Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease Proc. Natl. Acad. Sci. U. S. A. 1996 93 2696 2701
50. Q. Liu A. K. Raina M. A. Smith L. M. Sayre G. Perry Hydroxynonenal, toxic carbonyls, and Alzheimer disease Mol. Aspects Med. 2003 24 305 313
51. K. S. Montine P. J. Kim S. J. Olson W. R. Markesbery T. J. Montine 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease J. Neuropathol. Exp. Neurol. 1997 56 866 871
52. T. C. Murphy V. Amarnath M. J. Picklo Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex J. Neurochem. 2003 84 1313 1321
53. N. Traverso S. Menini P. Odetti M. A. Pronzato D. Cottalasso U. M. Marinari Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver Free Radical Biol. Med. 2002 32 350 359
54. J. J. Chen D. R. Petersen S. Schenker G. I. Henderson Formation of malondialdehyde adducts in livers of rats exposed to ethanol: Role in ethanol-mediated inhibition of cytochrome c oxidase Alcohol.: Clin. Exp. Res. 2000 24 544 552
55. J. Turchan C. B. Pocernich C. Gairola A. Chauhan G. Schifitto D. A. Butterfield S. Buch O. Narayan A. Sinai J. Geiger J. R. Berger H. Elford A. Nath Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants Neurology 2003 60 307 314
56. H. L. Rittner V. Hafner P. A. Klimiuk L. I. Szweda J. J. Goronzy C. M. Weyand Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis J. Clin. Invest 1999 103 1007 1013
57. H. L. Rittner M. Kaiser A. Brack L. I. Szweda J. J. Goronzy C. M. Weyand Tissue-destructive macrophages in giant cell arteritis Circ. Res. 1999 84 1050 1058
58. M. Benderdour G. Charron D. deBlois B. Comte C. Des Rosiers Cardiac mitochondrial NADP(+)-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation - An event that precedes hypertrophy development J. Biol. Chem. 2003 278 45154 45159
59. T. Ide H. Tsutsui S. Kinugawa H. Utsumi D. Kang N. Hattori K. Uchida K. Arimura K. Egashira A. Takeshita Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium Circ. Res. 1999 85 357 363
60. S. Srivastava B. Chandrasekar A. Bhatnagar S. D. Prabhu Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase Am. J. Physiol.: Heart Circ. Physiol. 2002 283 H2612 H2619
61. J. Chen G. I. Henderson G. L. Freeman Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart J. Mol. Cell. Cardiol. 2001 33 1919 1927
62. D. T. Lucas L. I. Szweda Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase Proc. Natl. Acad. Sci. U. S. A. 1999 96 6689 6693
63. A. Musatov C. A. Carroll Y. C. Liu G. I. Henderson S. T. Weintraub N. C. Robinson Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal Biochemistry 2002 41 8212 8220
64. K. Shinmura R. Bolli S. Q. Liu X. L. Tang E. Kodani Y. T. Xuan S. Srivastava A. Bhatnagar Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning Circ. Res. 2002 91 240 246
65. M. Veronneau B. Comte R. C. Des Quantitative gas chromatographic-mass spectrometric assay of 4-hydroxynonenal bound to thiol proteins in ischemic/reperfused rat hearts Free Radical Biol. Med. 2002 33 1380 1388
66. A. Fukuda Y. Nakamura H. Ohigashi T. Osawa K. Uchida Cellular response to the redox active lipid peroxidation products: induction of glutathione S-transferase P by 4-hydroxy-2-nonenal Biochem. Biophys. Res. Commun. 1997 236 505 509
67. S. Pugazhenthi K. Phansalkar G. Audesirk A. West L. Cabell Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal Free Radical Biol. Med. 2006 40 21 34
68. S. Srivastava M. Spite J. O. Trent M. B. West Y. Ahmed A. Bhatnagar Aldose reductase-catalyzed reduction of aldehyde phospholipids J. Biol. Chem. 2004 279 53395 53406
69. E. A. Podrez E. Poliakov Z. Shen R. Zhang Y. Deng M. Sun P. J. Finton L. Shan B. Gugiu P. L. Fox H. F. Hoff R. G. Salomon S. L. Hazen Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 J. Biol. Chem. 2002 277 38503 38516
70. A. D. Watson N. Leitinger M. Navab K. F. Faull S. Horkko J. L. Witztum W. Palinski D. Schwenke R. G. Salomon W. Sha G. Subbanagounder A. M. Fogelman J. A. Berliner Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo J. Biol. Chem. 1997 272 13597 13607
71. G. Subbanagounder J. W. Wong H. Lee K. F. Faull E. Miller J. L. Witztum J. A. Berliner Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta J. Biol. Chem. 2002 277 7271 7281
72. M. K. Chang C. J. Binder Y. I. Miller G. Subbanagounder G. J. Silverman J. A. Berliner J. L. Witztum Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory J. Exp. Med. 2004 200 1359 1370
73. N. Leitinger A. D. Watson S. Y. Hama B. Ivandic J. H. Qiao J. Huber K. F. Faull D. S. Grass M. Navab A. M. Fogelman F. C. de Beer A. J. Lusis J. A. Berliner Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 1999 19 1291 1298
74. S. Tsimikas S. Kiechl J. Willeit M. Mayr E. R. Miller F. Kronenberg Q. Xu C. Bergmark S. Weger F. Oberhollenzer J. L. Witztum Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study J. Am. Coll. Cardiol. 2006 47 2219 2228
75. A. Ravandi S. Babaei R. Leung J. C. Monge G. Hoppe H. Hoff H. Kamido A. Kuksis Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development Lipids 2004 39 97 109
76. J. A. Berliner A. D. Watson A role for oxidized phospholipids in atherosclerosis N. Engl. J. Med. 2005 353 9 11
77. D. W. Nebert V. Vasiliou Analysis of the glutathione S-transferase (GST) gene family Hum. Genomics 2004 1 460 464
78. O. B. van J. J. Bogaards W. H. Peters B. Blaauboer P. J. van Bladeren Quantification of human hepatic glutathione S-transferases Biochem. J. 1990 269 609 613
79. J. D. Hayes J. U. Flanagan I. R. Jowsey Glutathione transferases Annu. Rev. Pharmacol. Toxicol. 2005 45 51 88
80. K. Berhane M. Widersten A. Engstrom J. W. Kozarich B. Mannervik Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases Proc. Natl. Acad. Sci. U. S. A. 1994 91 1480 1484
81. A. K. Whitbread A. Masoumi N. Tetlow E. Schmuck M. Coggan P. G. Board Characterization of the omega class of glutathione transferases Methods Enzymol. 2005 401 78 99
82. S. S. Singhal P. Zimniak S. Awasthi J. T. Piper N. G. He J. I. Teng D. R. Petersen Y. C. Awasthi Several closely related glutathione S-transferase isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in human tissues Arch. Biochem. Biophys. 1994 311 242 250
83. N. G. He S. Awasthi S. S. Singhal M. B. Trent P. J. Boor The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall Toxicol. Appl. Pharmacol. 1998 152 83 89
84. S. S. Singhal J. T. Piper S. K. Srivastava M. Chaubey J. Bandorowicz-Pikula S. Awasthi Y. C. Awasthi Rabbit aorta glutathione S-transferases and their role in bioactivation of trinitroglycerin Toxicol. Appl. Pharmacol. 1996 140 378 386
85. Y. Yang Y. Yang M. B. Trent N. He S. D. Lick P. Zimniak Y. C. Awasthi P. J. Boor Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis Atherosclerosis 2004 173 211 221
86. N. G. He S. S. Singhal M. Chaubey S. Awasthi P. Zimniak C. A. Partridge Y. C. Awasthi Purification and characterization of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme from bovine pulmonary microvessel endothelial cells Biochim. Biophys. Acta 1996 1291 182 188
87. Z. Cao M. Tsang H. Zhao Y. Li Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury Biochem. Biophys. Res. Commun. 2003 310 979 985
88. Z. Cao D. Hardej L. D. Trombetta M. A. Trush Y. Li Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity Atherosclerosis 2003 166 291 301
89. Z. Cao Y. Li Chemical induction of cellular antioxidants affords marked protection against oxidative injury in vascular smooth muscle cells Biochem. Biophys. Res. Commun. 2002 292 50 57
90. Y. Li Z. Cao H. Zhu Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress Pharmacol. Res. 2006 53 6 15
91. P. Misra S. K. Srivastava S. S. Singhal S. Awasthi Y. C. Awasthi P. J. Boor Glutathione S-transferase 8-8 is localized in smooth muscle cells of rat aorta and is induced in an experimental model of atherosclerosis Toxicol. Appl. Pharmacol. 1995 133 27 33
92. N. G. He S. Awasthi S. S. Singhal M. B. Trent P. J. Boor The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall Toxicol. Appl. Pharmacol. 1998 152 83 89
93. D. J. Conklin P. J. Boor Allylamine cardiovascular toxicity: evidence for aberrant vasoreactivity in rats Toxicol. Appl. Pharmacol. 1998 148 245 251
94. Z. Cao Y. Li Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury Eur. J. Pharmacol. 2004 489 39 48
95. Z. Cao M. Tsang H. Zhao Y. Li Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury Biochem. Biophys. Res. Commun. 2003 310 979 985
96. Z. Cao D. Hardej L. D. Trombetta M. A. Trush Y. Li Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity Atherosclerosis 2003 166 291 301
97. Z. Cao Y. Li Chemical induction of cellular antioxidants affords marked protection against oxidative injury in vascular smooth muscle cells Biochem. Biophys. Res. Commun. 2002 292 50 57
98. M. N. Giraud M. Fluck C. Zuppinger T. M. Suter Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1beta J. Appl. Physiol 2005 99 313 322
99. A. S. Doney S. Lee G. P. Leese A. D. Morris C. N. Palmer Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study Circulation 2005 111 2927 2934
100. J. Schwartz S. K. Park M. S. O'Neill P. S. Vokonas D. Sparrow S. Weiss K. Kelsey Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction Am. J. Respir. Crit. Care Med. 2005 172 1529 1533
101. A. S. Doney S. Lee G. P. Leese A. D. Morris C. N. Palmer Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study Circulation 2005 111 2927 2934
102. D. Hyndman D. R. Bauman V. V. Heredia T. M. Penning The aldo-keto reductase superfamily homepage Chem.-Biol. Interact. 2003 143-144 621 631
103. S. K. Srivastava K. V. Ramana A. Bhatnagar Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options Endocrinol. Rev. 2005 26 380 392
104. S. Srivastava A. Chandra N. H. Ansari S. K. Srivastava A. Bhatnagar Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal Biochem. J. 1998 329 469 475
105. S. Srivastava A. Chandra L. F. Wang W. E. Seifert, Jr. B. B. Dague N. H. Ansari S. K. Srivastava A. Bhatnagar Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart J. Biol. Chem. 1998 273 10893 10900
106. S. Srivastava B. L. Dixit J. Cai S. Sharma H. E. Hurst A. Bhatnagar S. K. Srivastava Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: Role of aldose reductase Free Radical Biol. Med. 2000 29 642 651
107. S. Srivastava D. J. Conklin S. Q. Liu N. Prakash P. J. Boor S. K. Srivastava A. Bhatnagar Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells Atherosclerosis 2001 158 339 350
108. S. Srivastava S. J. Watowich J. M. Petrash S. K. Srivastava A. Bhatnagar Structural and kinetic determinants of aldehyde reduction by aldose reductase Biochemistry 1999 38 42 54
109. B. L. Dixit G. K. Balendiran S. J. Watowich S. Srivastava K. V. Ramana J. M. Petrash A. Bhatnagar S. K. Srivastava Kinetic and structural characterization of the glutathione-binding site of aldose reductase J. Biol. Chem. 2000 275 21587 21595
110. K. V. Ramana B. L. Dixit S. Srivastava G. K. Balendiran S. K. Srivastava A. Bhatnagar Selective recognition of glutathiolated aldehydes by aldose reductase Biochemistry 2000 39 12172 12180
111. K. Shinmura R. Bolli S. Q. Liu X. L. Tang E. Kodani Y. T. Xuan S. Srivastava A. Bhatnagar Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning Circ. Res. 2002 91 240 246
112. H. L. Rittner V. Hafner P. A. Klimiuk L. I. Szweda J. J. Goronzy C. M. Weyand Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis J. Clin. Invest. 1999 103 1007 1013
113. H. L. Rittner M. Kaiser A. Brack L. I. Szweda J. J. Goronzy C. M. Weyand Tissue-destructive macrophages in giant cell arteritis Circ. Res. 1999 84 1050 1058
114. K. Shinmura R. Bolli S. Q. Liu X. L. Tang E. Kodani Y. T. Xuan S. Srivastava A. Bhatnagar Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning Circ. Res. 2002 91 240 246
115. G. Suarez Nonenzymatic browning of proteins and the sorbitol pathway. Progr. Clin. Biol. Res. 1989 304 141 62
116. H. Kato N. van Chuyen T. Shinoda F. Sekiya F. Hayase Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats Biochim. Biophys. Acta 1990 1035 71 6
117. T. Kanazu M. Shinoda T. Nakayama Y. Deyashiki A. Hara H. Sawada Aldehyde reductase is a major protein associated with 3-deoxyglucosone reductase activity in rat, pig and human livers Biochem. J. 1991 279 903 6
118. Z. Q. Liang F. Hayase H. Kato Purification and characterization of NADPH-dependent 2-oxoaldehyde reductase from porcine liver. A self-defence enzyme preventing the advanced stage of the Maillard reaction. Eur. J. Biochem. 1991 373 379
119. M. Takahashi J. Fujii T. Teshima K. Suzuki T. Shiba N. Taniguchi Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression Gene 1993 127 249 53
120. K. Matsuura K. Sato Y. Deyashiki M. Nakanishi A. Hara 3-Deoxyglucosone reductase in dog adrenal glands. Identification as aldose reductase Biol. Pharm. Bull. 1995 18 1765 7
121. K. Sato A. Inazu S. Yamaguchi T. Nakayama Y. Deyashiki H. Sawada A. Hara Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase Arch. Biochem. Biophys. 1993 307 286 94
122. E. Fujii H. Iwase I. Ishii-Karakasa Y. Yajima K. Hotta The presence of 2-keto-3-deoxygluconic acid and oxoaldehyde dehydrogenase activity in human erythrocytes Biochem. Biophys. Res. Commun. 1995 210 852 7
123. S. Lal B. S. Szwergold A. H. Taylor W. C. Randall F. Kappler K. Wells-Knecht J. W. Baynes T. R. Brown Metabolism of fructose-3-phosphate in the diabetic rat lens Arch. Biochem. Biophys. 1995 318 191 9
124. S. Tsukushi T. Katsuzaki I. Aoyama F. Takayama T. Miyazaki K. Shimokata T. Niwa Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway Kidney Int. 1999 55 1970 6
125. Y. Hamada J. Nakamura K. Naruse T. Komori K. Kato Y. Kasuya R. Nagai S. Horiuchi N. Hotta Epalrestat, an aldose reductase inhibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients Diabetes Care 2000 23 10 1539 44
126. K. Suzuki Y. H. Koh H. Mizuno R. Hamaoka N. Taniguchi Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone J. Biochem. 1998 123 353 7
127. K. E. Stremler D. M. Stafforini S. M. Prescott G. A. Zimmerman T. M. McIntyre An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma J. Biol. Chem. 1989 264 5331 5334
128. K. E. Stremler D. M. Stafforini S. M. Prescott T. M. McIntyre Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates 1 J. Biol. Chem. 1991 266 11095 11103
129. S. M. Prescott G. A. Zimmerman D. M. Stafforini T. M. McIntyre Platelet-activating factor and related lipid mediators Annu. Rev. Biochem. 2000 69 419 445
130. A. Matsuzawa K. Hattori J. Aoki H. Arai K. Inoue Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II J. Biol. Chem. 1997 272 32315 32320
131. D. M. Stafforini J. R. Sheller T. S. Blackwell A. Sapirstein F. E. Yull T. M. McIntyre J. V. Bonventre S. M. Prescott L. J. Roberts Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases J. Biol. Chem. 2006 281 4616 4623
132. A. D. Watson M. Navab S. Y. Hama A. Sevanian S. M. Prescott D. M. Stafforini T. M. McIntyre B. N. Du A. M. Fogelman J. A. Berliner Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein J. Clin. Invest. 1995 95 774 782
133. R. Quarck B. De Geest D. Stengel A. Mertens M. Lox G. Theilmeier C. Michiels M. Raes H. Bult D. Collen P. Van Veldhoven E. Ninio P. Holvoet Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice Circulation 2001 103 2495 2500
134. S. Srivastava M. Spite J. O. Trent M. B. West Y. Ahmed A. Bhatnagar Aldose reductase-catalyzed reduction of aldehyde phospholipids J. Biol. Chem. 2004 279 53395 53406
135. G. Subbanagounder N. Leitinger D. C. Schwenke J. W. Wong H. Lee C. Rizza A. D. Watson K. F. Faull A. M. Fogelman J. A. Berliner Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position Arterioscl., Thromb., Vasc. Biol. 2000 2248 2254
136. P. J. Thornalley Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 2003 31 1343 8
137. M. Ridderstrom F. Saccucci U. Hellman T. Bergman G. Principato B. Mannervik Molecular cloning, heterologous expression, and characterization of human glyoxalase II J. Biol. Chem. 1996 271 319 23
138. P. A. Cordell T. S. Futers P. J. Grant R. J. Pease The Human hydroxyacylglutathione hydrolase (HAGH) gene encodes both cytosolic and mitochondrial forms of glyoxalase II J. Biol. Chem. 2004 279 28653 61
139. V. Talesa L. Uotila M. Koivusalo G. Principato E. Giovannini G. Rosi Demonstration of glyoxalase II in rat liver mitochondria. Partial purification and occurrence in multiple forms Biochim. Biophys. Acta 1988 955 103 110
140. M. Shinohara P. J. Thornalley I. Giardino P. Beisswenger S. R. Thorpe J. Onorato M. Brownlee Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis J. Clin. Invest. 1998 101 1142 1147
141. A. G. Miller D. G. Smith M. Bhat R. H. Nagaraj Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions J. Biol. Chem. 2006 281 11864 71
142. S. A. Phillips D. Mirrlees P. J. Thornalley Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil Biochem. Pharmacol. 1993 46 805 811
143. A. Mitsumoto K. R. Kim G. Oshima M. Kunimoto K. Okawa A. Iwamatsu Y. Nakagawa Glyoxalase I is a novel nitric-oxide-responsive protein Biochem. J. 1999 344 837 44
144. A. Mitsumoto K. R. Kim G. Oshima M. Kunimoto K. Okawa A. Iwamatsu Y. Nakagawa Nitric oxide inactivates glyoxalase I in cooperation with glutathione J. Biochem. 2000 128 647 54
145. A. G. Miller D. G. Smith M. Bhat R. H. Nagaraj Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions J. Biol. Chem. 2006 281 11864 71
146. A. Mitsumoto K. R. Kim G. Oshima Y. Nakagawa Inhibitory effects of S-nitrosoglutathione on cell proliferation and DNA synthesis: possible role of glyoxalase I inactivation Chem.-Biol. Interact. 2001 137 105 21
147. F. Van Herreweghe J. Mao F. W. Chaplen J. Grooten K. Gevaert J. Vandekerckhove K. Vancompernolle Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE Proc. Natl. Acad. Sci. U. S. A. 2002 99 949 54
148. I. Hovatta R. S. Tennant R. Helton R. A. Marr O. Singer J. M. Redwine J. A. Ellison E. E. Schadt I. M. Verma D. J. Lockhart C. Barlow Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice Nature 2005 438 662 6
149. F. Chen M. A. Wollmer F. Hoerndli G. Munch B. Kuhla E. I. Rogaev M. Tsolaki A. Papassotiropoulos J. Gotz Role for glyoxalase I in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 2004 101 7687 92
150. D. L. Vander Jagt B. Robinson K. K. Taylor L. A. Hunsaker Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications J. Biol. Chem. 1992 267 4364 4369
151. J. L. Casazza J. L. Fu Measurement of acetol in serum Anal. Biochem. 1985 148 344 348
152. G. A. Reichard, Jr. C. L. Skutches R. D. Hoeldtke O. E. Owen Acetone metabolism in humans during diabetic ketoacidosis Diabetes 1986 35 668 674
153. J. Aguilera J. A. Prieto The Saccharomyces cerevisiae aldose reductase is implied in the metabolism of methylglyoxal in response to stress conditions Curr. Genet. 2001 39 5-6 273 83
154. K. C. Chang K. S. Paek H. J. Kim Y. S. Lee C. Yabe-Nishimura H. G. Seo Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes Mol. Pharmacol. 2002 61 5 1184 1191
155. D. L. Vander Jagt L. A. Hunsaker Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase Chem.-Biol. Interact. 2003 143-144 341 51
156. C. L. Skutches O. E. Owen G. A. Reichard, Jr. Acetone and acetol inhibition of insulin-stimulated glucose oxidation in adipose tissue and isolated adipocytes Diabetes 1990 39 450 455
157. V. Vasiliou A. Pappa D. R. Petersen Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism Chem.-Biol. Interact. 2000 129 1 19
158. J. S. Boesch C. Lee R. G. Lindahl Constitutive expression of class 3 aldehyde dehydrogenase in cultured rat corneal epithelium J. Biol. Chem. 1996 271 5150 5157
159. N. E. Sladek, Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines, in Anticancer Drugs: Reactive Metabolism and Drug Interactions, ed., G. Powis,, Pergamon Press, 1994, 79 -156
160. N. E. Sladek Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines Curr. Pharm. Des. 1999 5 607 625
161. L. Sreerama N. E. Sladek Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Cancer Institute to screen for potentially useful antitumor agents Adv. Exp. Med. Biol. 1997 414 81 94
162. J. S. Boesch R. Miskimins W. K. Miskimins R. Lindahl The same xenobiotic response element is required for constitutive and inducible expression of the mammalian aldehyde dehydrogenase-3 gene Arch. Biochem. Biophys. 1999 361 223 230
163. T. J. Dunn R. Lindahl H. C. Pitot Differential gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Noncoordinate regulation of a TCDD-induced aldehyde dehydrogenase and cytochrome P-450c in the rat J. Biol. Chem. 1988 263 10878 10886
164. V. Vasiliou A. Pappa D. R. Petersen Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism Chem.-Biol. Interact. 2000 129 1 19
165. L. B. Sanchez Aldehyde dehydrogenase (CoA-acetylating) and the mechanism of ethanol formation in the amitochondriate protist, Giardia lamblia Arch. Biochem. Biophys. 1998 354 57 64
166. P. McCaffery E. Wagner J. O'Neil M. Petkovich U. C. Drager Dorsal and ventral rentinoic territories defined by retinoic acid synthesis, break-down and nuclear receptor expression Mech. Dev. 1999 85 203 214
167. K. Niederreither V. Subbarayan P. Dolle P. Chambon Embryonic retinoic acid synthesis is essential for early mouse post-implantation development Nat. Genet. 1999 21 444 448
168. S. Harada D. P. Agarwal H. W. Goedde Aldehyde dehydrogenase polymorphism and alcohol metabolism in alcoholics Alcohol 1985 2 391 392
169. G. S. Peng M. F. Wang C. Y. Chen S. U. Luu H. C. Chou T. K. Li S. J. Yin Involvement of acetaldehyde for full protection against alcoholism by homozygosity of the variant allele of mitochondrial aldehyde dehydrogenase gene in Asians Pharmacogenetics 1999 9 463 476
170. Leiber and P. Alcoholic liver disease: New insights in pathogenesis lead to new treatments. J. Hepatol., 32, 113-128. 2000
171. Z. Amit Z. W. Brown G. E. Rockman B. Smith S. Amir Acetaldehyde: a positive reinforcer mediating ethanol consumption Adv. Exp. Med. Biol. 1980 126 413 423
172. S. S. Singhal J. T. Piper S. K. Srivastava M. Chaubey J. Bandorowicz-Pikula S. Awasthi Y. C. Awasthi Rabbit aorta glutathione S-transferases and their role in bioactivation of trinitroglycerin Toxicol. Appl. Pharmacol. 1996 140 378 386
173. S. R. Kenkare L. Z. Benet Tolerance to nitroglycerin in rabbit aorta. Investigating the involvement of the mu isozyme of glutathione S-transferases Biochem. Pharmacol. 1996 51 1357 1363
174. S. R. Kenkare C. Han L. Z. Benet Correlation of the response to nitroglycerin in rabbit aorta with the activity of the mu class glutathione S-transferase Biochem. Pharmacol. 1994 48 2231 2235
175. L. V. De G. R. Rogers D. J. Hamrock L. N. Marekov P. M. Steinert J. G. Compton N. Markova W. B. Rizzo Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene Nat. Genet. 1996 12 52 57
176. W. B. Rizzo A. L. Dammann D. A. Craft Sjogren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity J. Clin. Invest. 1988 81 738 744
177. Z. J. Liu Y. J. Sun J. Rose Y. J. Chung C. D. Hsiao W. R. Chang I. Kuo J. Perozich R. Lindahl J. Hempel B. C. Wang The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold Nat. Struct. Biol. 1997 4 317 326
178. J. E. Downes P. G. Swann R. S. Holmes A genetic basis for corneal sensitivity to ultraviolet light among recombinant SWXJ inbred strains of mice Curr. Eye Res. 1997 16 539 546
179. M. Numazawa M. Nagaoka N. Sohtome Aromatase reaction of 3-deoxyandrogens: steric mode of the C-19 oxygenation and cleavage of the C10-C19 bond by human placental aromatase Biochemistry 2005 44 10839 10845
180. T. Matsunaga Y. Iwawaki K. Watanabe S. Narimatsu I. Yamamoto S. Imaoka Y. Funae H. Yoshimura Cytochrome P450 isozymes catalyzing the hepatic microsomal oxidation of 9-anthraldehyde to 9-anthracene carboxylic acid in adult male rats Biol. Pharm. Bull. 1993 16 866 869
181. K. Watanabe T. Matsunaga S. Narimatsu I. Yamamoto S. Imaoka Y. Funae H. Yoshimura Catalytic activity of cytochrome P450 isozymes purified from rat liver in converting 11-oxo-delta 8-tetrahydrocannabinol to delta 8- tetrahydrocannabinol-11-oic acid Biochem. Pharmacol. 1991 42 1255 1259
182. K. Watanabe S. Narimatsu T. Matsunaga I. Yamamoto H. Yoshimura A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes Biochem. Pharmacol. 1993 46 405 411
183. S. Marini E. Grasso V. Longo P. Puccini B. Riccardi P. G. Gervasi 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human Xenobiotica 2003 33 1 11
184. T. Amunom, L. J. Stephens, D. J. Conklin, S. Srivastava, A. Bhatnagar and R. A. Prough, Several cytochromes P450 are aldehyde monooxygenases. in Enzymology and Molecular Biology of Carbonyl Metabolism, ed., H. Weiner, 12, 118-123. 2005, Layafette, IN, U. Purdue Press
185. T. Ishii K. Itoh E. Ruiz D. S. Leake H. Unoki M. Yamamoto G. E. Mann Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal Circ. Res. 2004 94 609 616
186. D. Yao T. Taguchi T. Matsumura R. Pestell D. Edelstein I. Giardino G. Suske N. Ahmed P. J. Thornalley V. P. Sarthy H. P. Hammes M. Brownlee Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Cell 2006 124 2 275 86
187. E. A. Podrez E. Poliakov Z. Shen R. Zhang Y. Deng M. Sun P. J. Finton L. Shan B. Gugiu P. L. Fox H. F. Hoff R. G. Salomon S. L. Hazen Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 J. Biol. Chem. 2002 277 38503 38516
188. H. Lee W. Shi P. Tontonoz S. Wang G. Subbanagounder C. C. Hedrick S. Hama C. Borromeo R. M. Evans J. A. Berliner L. Nagy Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells Circ. Res. 2000 87 516 521
189. C. J. Proudfoot E. M. Garry D. F. Cottrell R. Rosie H. Anderson D. C. Robertson S. M. Fleetwood-Walker R. Mitchell Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain Curr. Biol. 2006 16 1591 1605
190. C. Vindis I. Escargueil-Blanc M. Elbaz B. Marcheix M. H. Grazide K. Uchida R. Salvayre A. Negre-Salvayre Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers Circ. Res. 2006 98 785 792